Among patients undergoing #CancerSurgery for 6 major nonmetastatic cancers, time from diagnosis to first-course therapy increased from 2012 to 2023 across all malignancies and among both up-front surgery and #NeoadjuvantTherapy pathways.

ja.ma/4wooXr0

Want to know more about adjuvant and neoadjuvant therapies?
Watch full video here- https://youtu.be/cG_cJNn0qbA?si=Xa7SiaQwy-MqIPT1

#acureinsight #ocularmelanoma #om #neoadjuvanttherapy #adjuvanttherapy #cancerjourney #cancertreatment

Want to know more about adjuvant and neoadjuvant therapies?
Watch full video here-https://youtu.be/cG_cJNn0qbA?si=ERv3AUEgqpOv7-mL

#om #ocularmelanoma #ocularmelanomaawareness #omies #adjuvanttherapy #neoadjuvanttherapy #cancerjourney #acureinsight

Learn more HERE 👉https://melanomafocus.org/news-blog/neoadjuvant-therapy-has-been-approved-by-nhs-england/

#Melanoma #CancerTreatment #Immunotherapy #SkinCancer #CancerCare #MelanomaAwareness #NHSEngland #NeoadjuvantTherapy #AdjuvantTherapy

(4/4)

Combining #camrelizumab and #apatinib with #chemotherapy showed strong efficacy, manageable toxicity, and robust immune activation, highlighting its promise as an effective #NeoadjuvantTherapy. #medsky

#OpenAccess in #STTT: doi.org/10.1038/s413...

A single-center, nonrandomized #ClinicalTrial shows promising efficacy and safety for a #NeoadjuvantTherapy comprising camrelizumab and apatinib along with chemotherapy for stage II-III triple-negative breast cancer (#TNBC). #medsky

Latest in #STTT #OpenAccess: www.nature.com/articles/s41...